Trading Radar for 03/09: Carnival (CCL), Ann, Inc. (ANN), Delcath (DCTH), Citi Trends (CTRN) Report

The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:

Before The Market Opens
Economic:
8:30am EST

• Nonfarm Payrolls - Street sees 206K
  
  
• Nonfarm Private Payrolls - Street sees 220K
  
  
• Unemployment Rate - Street sees 8.3%
  
  
• Hourly Earnings - Street sees 0.2%
  
  
• Average Workweek - Street sees 34.5
  
  
• Trade Balance - Street sees ($48.2B)

Earnings:

Ann, Inc. (NYSE: ANN) - consensus EPS $0.29
Ballantyne Strong, Inc. (NYSE: BTN) - no Street consensus
BioScrip, Inc. (Nasdaq: BIOS) - consensus EPS $0.10
BioSpecifics Technologies Corp. (Nasdaq: BSTC) - no Street consensus
Carnival Corp. (NYSE: CCL) - consensus EPS $0.00
China Automotive Systems, Inc. (Nasdaq: CAAS) - consensus EPS $0.15
Citi Trends, Inc. (Nasdaq: CTRN) - consensus loss $0.20
Delcath Systems, Inc. (Nasdaq: DCTH) - consensus loss $0.28
Dolan Company (NYSE: DM) - consensus EPS $0.09
Halozyme Therapeutics, Inc. (Nasdaq: HALO) - consensus loss $0.15
Hibbett Sports, Inc. (Nasdaq: HIBB) - consensus EPS $0.56
LMI Aerospace, Inc. (Nasdaq: LMIA) - consensus EPS $0.41
MI Developments Inc. (NYSE: MIM) - no Street consensus
Novavax, Inc. (Nasdaq: NVAX) - consensus loss $0.04
Ocean Power Technologies, Inc. (Nasdaq: OPTT) - no Street consensus
U.S. Concrete, Inc. (Nasdaq: USCR) - consensus loss $0.35

Intraday or Not Specified
Economics:
10:00am EST

• Wholesale Inventories - Street sees 0.6%

After the Market Closes
Earnings:

Chindex International, Inc. (Nasdaq: CHDX) - consensus EPS $0.05
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) - consensus loss $0.13

Check out our Earnings Insider for news and updates on earnings as they happen!

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Iridium Communications (IRDM) Reports In-Line Q1 EPS; offers outlook
• Tesla, Blackstone, Las Vegas Sands fall premarket; DR Horton rises
• Intelligent Bio Solutions (INBS) Reports Prelim Q3 Results